Engineering topics

Johnstone, Carol

Publications and source records attributed to Johnstone, Carol.

4 records

DOE OSTI2024

Secondary Beamline Lattice Design at the MeV Test Area (MTA)

The MTA is currently configured to produce a secondary pion beam from a tungsten target, which subsequently generates muons from decay in flight. In its present lattice configuration, the currently installed air core quadrupoles are strength-limited in their ability to deliver a high muon flux to the end user. Recently, seven strong iron-core quadrupole spares from the 400-MeV Linac were acquired. Based on these quadrupoles, a new lattice has been designed that maximizes both pion transport and muon capture the line based on significantly shorter magnetic lengths, strong magnetic gradients, and consequently an enhanced angular acceptance. For this project, we demonstrated that the ratio of muons to pions increased by over an order of magnitude (approximately 75 for lattice configurations were studied), successfully capturing a phase space area as large as 13.2 [mm] x 24 [mRad] in simulation.

Winter, Wesley↗

DOE OSTI2024

Low-energy muon and muonium beam source at Fermilab

We describe a high-efficiency source of muonium that can be transported as a beam in vacuum provides opportunities for fundamental muon and precision physics measurements such as sensitive searches for symmetry violation. Although PSI is currently the world leader, the intense 800-MeV PIP-II linac beam at Fermilab could provide world-class low-energy muon and muonium beams, with unparalleled intensity, driving the next generation of precision muon-based physics experiments at the intensity frontier. However, it is critical to initiate the prerequisite R&D now to prepare for the PIP-II era. A low-energy secondary muon line recently installed in an operating facility (the MeV Test Area, which utilizes the intense 400-MeV Fermilab Linac beam) could support the required R&D, and potentially compete for new physics in the immediate term, if approved. This beamline was developed for μ– and will need to be re-optimized for surface μ+ production and transport, making it also suitable for muon spin rotation physics––a unique research and industrial application for which no U.S. facility exists, and whose facilities are oversubscribed worldwide.

43 PARTICLE ACCELERATORS↗

DOE OSTI2023

A new center for heavy ion research

Progress in cancer therapy with ions heavier than protons, i.e., helium, carbon, oxygen and neon, requires research and development capability. Ion research activity, however, is limited from the absence of U.S. accelerator facilities offering ion beams for therapy – placing the U.S. significantly behind Europe and Asia. With dramatic advances in beam delivery and compact accelerators, the potential exists to create a facility that can play a leadership role in particle therapy and ion-based research. This paper announces summary details of a new center for ion therapy research under construction in Waco, TX, in collaboration with recognized accelerator entities both academic and industrial. The advanced accelerator technologies will produce beams for both clinical and research applications, offering a complete range of ions, intensities and energies required by the medical community, including the capability to perform ultra-high dose irradiation (FLASH) research. FLASH, a recent research initiative, which has the potential of reducing cancer treatment toxicities, is an important if not critical capability for a competitive research center – requiring beam intensities well beyond those provided by current medical accelerators. Building a state-of-the-art cancer research center within a comprehensive facility will provide the resources to promote ion therapy in the U.S, including, preclinical/clinical trials and protocols between modalities, and also support broad ion R&D.

43 PARTICLE ACCELERATORS↗

DOE OSTI2023

Transformative Technology for FLASH Radiation Therapy

The general concept of radiation therapy used in conventional cancer treatment is to increase the therapeutic index by creating a physical dose differential between tumors and normal tissues through precision dose targeting, image guidance, and radiation beams that deliver a radiation dose with high conformality, e.g., protons and ions. However, the treatment and cure are still limited by normal tissue radiation toxicity, with the corresponding side effects. A fundamentally different paradigm for increasing the therapeutic index of radiation therapy has emerged recently, supported by preclinical research, and based on the FLASH radiation effect. FLASH radiation therapy (FLASH-RT) is an ultra-high-dose-rate delivery of a therapeutic radiation dose within a fraction of a second. Experimental studies have shown that normal tissues seem to be universally spared at these high dose rates, whereas tumors are not. While dose delivery conditions to achieve a FLASH effect are not yet fully characterized, it is currently estimated that doses delivered in less than 200 ms produce normal-tissue-sparing effects, yet effectively kill tumor cells. Despite a great opportunity, there are many technical challenges for the accelerator community to create the required dose rates with novel compact accelerators to ensure the safe delivery of FLASH radiation beams.

43 PARTICLE ACCELERATORS↗